SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-250405
Filing Date
2023-10-04
Accepted
2023-10-04 09:20:55
Documents
16
Period of Report
2023-09-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d539255d8k.htm   iXBRL 8-K 35467
2 EX-1.1 d539255dex11.htm EX-1.1 43900
3 EX-4.1 d539255dex41.htm EX-4.1 81561
4 EX-4.2 d539255dex42.htm EX-4.2 89593
5 EX-10.1 d539255dex101.htm EX-10.1 194788
  Complete submission text file 0001193125-23-250405.txt   688922

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA vcnx-20230928.xsd EX-101.SCH 2841
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE vcnx-20230928_lab.xml EX-101.LAB 17978
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vcnx-20230928_pre.xml EX-101.PRE 11252
10 EXTRACTED XBRL INSTANCE DOCUMENT d539255d8k_htm.xml XML 3390
Mailing Address 1895 MOUNT HOPE AVE ROCHESTER NY 14620
Business Address 1895 MOUNT HOPE AVE ROCHESTER NY 14620 585-271-2700
VACCINEX, INC. (Filer) CIK: 0001205922 (see all company filings)

IRS No.: 161603202 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38624 | Film No.: 231306701
SIC: 2834 Pharmaceutical Preparations